共 50 条
- [1] Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer [J]. Breast Cancer Research and Treatment, 2017, 162 : 39 - 48
- [3] Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma [J]. FRONTIERS IN ONCOLOGY, 2022, 12
- [8] Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis [J]. World Journal of Surgical Oncology, 18